Product Center
Products Center
Ⅰ. The company was rated as "2016 Excellent Industrial Enterprise of the City".
Ⅱ. The company was recognized as "Provincial Enterprise Technology Center".
Ⅲ. Bairui Granules entered the "National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)".
2021-09-14
Ⅰ. Won the 2015 Langya District Taxation "Top Ten" and "Top Ten" Enterprise Commendation.
Ⅱ. Become an innovative enterprise in Chuzhou City.
Ⅲ. Enpagliflozin products won the 2016 Major Science and Technology Project of Anhui Provincial Department of Science and Technology.
Ⅳ. The "Bomeixing" brand of Bairui preparation was awarded the recognition of famous trademark in Anhui Province.
2021-09-14
Ⅰ. Bairui Capsules (granules) were included in the "2012 Tianjin Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog".
Ⅱ. The project "Bairui Granules, the Millennium Heritage of Xin'an Medicine, Innovative Special Medicine for Children's Upper Respiratory Tract Infections" won the second prize of "Huaxia Healthcare International Promotion Science and Technology Award".
2021-09-14
Ⅰ. As a rare wild medicinal material, Pleurotus is listed as a key protected authentic medicinal material by the Anhui Provincial Government.
Ⅱ. Bairui Tablet was included in the List of Supplementary Drugs of Primary Medical Institutions in Shanghai.
2021-09-14
Bairui was shortlisted in the top 10 list of ENT drugs in Chinese hospitals in 2013.
2021-09-14
Bairui Tablets and Bairui Capsules obtained the National "Certificate of Protected Varieties of Traditional Chinese Medicine".
2021-09-14
Bairui tablets are listed as anti-infective botanicals in the "New Pharmacology" (16th edition), which is regarded as the authority of clinical medication by the majority of medical workers.
2021-09-14
Bairui Granules (sugar-free) was successfully launched, making an important contribution to the prevention and control of upper respiratory tract infections in children in China, and has become the main drug for the treatment of viral infections such as influenza and hand, foot and mouth disease.
2021-09-14
Ⅰ. Bairui's products have entered the "2010 Medical Insurance Drug List" in Shanghai, Jiangsu, Anhui, Hainan and other provinces.
Ⅱ. Bairui products are listed in the "Traditional Chinese Medicine Otolaryngology Clinical Diagnosis and Treatment
Guidelines" by the State Administration of Traditional Chinese Medicine.
2021-09-14
Bairui Tablets and Bairui Capsules were launched.
2021-09-14
